Zagreb, Croatia

Tonko Drazic

This inventor holds 1 USPTO granted patent. Top assignee: Rudjer Boskovic Institute. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tonko Drazic. Retrieved from https://idiyas.com/inventor/tonko-drazic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Tonko Drazic

Introduction

Tonko Drazic is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in the area of cholesterol absorption inhibitors. His work is aimed at addressing critical health issues such as atherosclerosis and high cholesterol levels.

Latest Patents

Tonko Drazic holds a patent for "Beta-lactam cholesterol absorption inhibitors." This invention relates to novel compounds represented by Formula (Ia) or (Ib) and their pharmaceutical preparations for the treatment of atherosclerosis and cholesterol level reduction. This patent highlights his innovative approach to tackling cardiovascular health challenges.

Career Highlights

Tonko Drazic is affiliated with the Ruđer Bošković Institute, where he conducts research and development in the field of pharmaceuticals. His work at this esteemed institution has allowed him to focus on creating effective solutions for health-related issues.

Collaborations

Tonko collaborates with Ivan Habus, a fellow researcher, to further enhance the impact of their work in the pharmaceutical sector. Their partnership exemplifies the importance of teamwork in driving innovation.

Conclusion

Tonko Drazic's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts underscore his commitment to improving health outcomes. His work continues to pave the way for advancements in cholesterol management and cardiovascular health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…